Form 4: Bicycle Therapeutics' Chief Technology Officer Sells Shares to Cover Tax Obligations

Michael Skynner, Chief Technology Officer of Bicycle Therapeutics PLC, sold 972 ordinary shares to cover tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

• On October 3, 2024, Michael Skynner, the Chief Technology Officer of Bicycle Therapeutics PLC, sold 972 ordinary shares of the company.
• The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
• The shares were sold at a weighted average price of $22.26, with individual transactions ranging from $21.91 to $22.56.
• Following the transaction, Skynner beneficially owns 92,945 ordinary shares of Bicycle Therapeutics PLC.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a routine sale of shares to cover tax obligations, with no indication of positive or negative implications for the company's performance.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It's common for executives to sell shares to cover taxes when RSUs vest.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates